Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of dermatology 2020-04, Vol.47 (4), p.e110-e111
Hauptverfasser:	Ito, Michiko, Hirota, Tomomitsu, Momose, Mami, Ito, Toshihiro, Umezawa, Yoshinori, Fukuchi, Osamu, Asahina, Akihiko, Nakagawa, Hidemi, Tamari, Mayumi, Saeki, Hidehisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - pharmacology Adalimumab - therapeutic use Adult Aged Asian Continental Ancestry Group - genetics Dermatologic Agents - pharmacology Dermatologic Agents - therapeutic use Drug Resistance - genetics Female Genotyping Techniques Humans Infliximab - pharmacology Infliximab - therapeutic use Japan Male Middle Aged Polymorphism, Single Nucleotide Psoriasis Psoriasis - drug therapy Psoriasis - genetics Receptors, Tumor Necrosis Factor, Type II - genetics Tumor Necrosis Factor alpha-Induced Protein 3 - genetics Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!